Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)
ENRICH-HNC
Community Health Support for Emergency Department-Presenting Head and Neck Cancer Patients: A Pilot to Improve Access to Timely Care
1 other identifier
interventional
24
1 country
2
Brief Summary
Patients diagnosed with head and neck cancer (HNC) after presenting to an emergency department (ED) often face significant delays in diagnosis and treatment. These patients are frequently younger, underinsured, and experience multiple socioeconomic and systems-level barriers to accessing timely cancer care. Delays of more than 30 days have been associated with worse outcomes, including higher recurrence rates and reduced survival. This pilot study will evaluate the feasibility and early impact of a community-based navigation program designed to improve access to timely care for ED-presenting HNC patients. The study embeds trained Community Health Support Specialists (CHSS) from the Engaging Navigators to Reduce Inequities in Cancer Health (ENRICH) program into the ED-to-treatment pathway. After ED discharge, CHSS staff will contact participants by telephone or text message to identify barriers to care-such as transportation, insurance, housing, or communication challenges-and connect them with appropriate community or institutional resources. All participants will receive the CHSS navigation intervention. Outcomes will be compared with a historical cohort of similar ED-presenting HNC patients treated prior to program implementation. The primary outcomes are time from ED discharge to diagnostic biopsy and time from ED discharge to initiation of definitive treatment. Secondary outcomes include feasibility, measured as the proportion of participants who complete CHSS navigation, and exploratory analyses of the types of barriers identified and resolved. Findings from this pilot will generate preliminary data to inform larger studies aimed at improving access, reducing disparities, and accelerating treatment for head and neck cancer patients who first present in the emergency setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2025
CompletedFirst Posted
Study publicly available on registry
November 10, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
January 22, 2026
January 1, 2026
12 months
November 4, 2025
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time From Emergency Department (ED) Presentation to Diagnostic Biopsy (Days)
Interval (days) between the date of ED discharge from the index visit and the date of the first diagnostic biopsy procedure performed to evaluate suspected head and neck cancer.
Up to 90 days after ED discharge
Time From Emergency Department (ED) Presentation to Treatment Initiation (Days)
Interval (days) between the date of ED discharge from the index visit and the start date of definitive treatment (surgery, radiation, systemic therapy, or combined modality) for head and neck cancer.
Up to 90 days after ED discharge
Secondary Outcomes (1)
Feasibility of Community Health Support Specialist (CHSS) Navigation
Up to 90 days after enrollment
Other Outcomes (2)
Number and Types of Social Barriers Identified During CHSS Encounters
Up to 90 days after enrollment
Number of Barriers Resolved Through CHSS Intervention
Up to 90 days after enrollment
Study Arms (1)
Community Health Support Specialist (CHSS) Navigation
EXPERIMENTALParticipants will receive structured, non-clinical navigation support from a trained Community Health Support Specialist (CHSS) initiated after emergency department discharge. CHSS outreach will occur by telephone or text message and will focus on identifying social and logistical barriers to timely cancer care (e.g., transportation, insurance, housing, communication), providing appropriate resource referrals, and reinforcing communication between patients and clinical care teams as needed. Each participant will receive a minimum of two CHSS contacts prior to initiation of definitive cancer treatment.
Interventions
This intervention consists of structured, non-clinical navigation delivered by trained Community Health Support Specialists (CHSS) as part of the Engaging Navigators to Reduce Inequities in Cancer Health (ENRICH) program. Following emergency department discharge and completion of electronic informed consent, CHSS staff conduct outreach by telephone or text message to identify and address social and logistical barriers to timely head and neck cancer care. Navigation activities may include assistance with transportation resources, insurance or financial navigation, connection to housing or community services, and reinforcement of communication between patients and clinical care teams. CHSS staff do not provide medical advice, schedule clinical appointments, or alter treatment plans. All navigation encounters are documented using standardized REDCap instruments.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Presentation to the emergency department (ED) with a new or suspected head and neck cancer (including oral cavity, oropharynx, hypopharynx, larynx, salivary gland, cutaneous, sinonasal, nasopharyngeal, thyroid, or metastatic disease with unknown primary)
- Residence within the regional catchment area of participating UTHSC-affiliated hospitals (Methodist University Hospital or Regional One Health)
- Ability to provide informed consent electronically using REDCap eConsent after ED discharge
- Has a valid telephone number for post-discharge contact
You may not qualify if:
- Prior or ongoing established head and neck oncology care at the time of ED presentation
- Currently receiving hospice or palliative-only care
- Incarcerated individuals
- Inability to complete electronic informed consent (e.g., lack of decisional capacity or inability to complete consent even with staff assistance)
- Lacks reliable telephone access or is unable to be reached after three documented contact attempts by study staff
- Non-English or non-Spanish speaking when interpreter services are unavailable
- Expected survival less than four weeks, as determined by the treating clinical team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Tennesseelead
- Methodist University Hospitalcollaborator
- Regional One Healthcollaborator
- UTHSC Center for Cancer Researchcollaborator
Study Sites (2)
Methodist University Hospital
Orlando, Florida, 32819, United States
Regional One Health
Memphis, Tennessee, 38103, United States
Related Links
- UTHSC news release describing the ENRICH program, a state-funded initiative led by Drs. Schwartz and Stewart to improve cancer care access through community health support specialists in West Tennessee.
- Official UTHSC Cancer Center webpage providing information about cancer research, pilot grant programs, and access-to-care initiatives supported by the institution.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Schwartz, MD
University of Tennessee
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2025
First Posted
November 10, 2025
Study Start
February 1, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
January 31, 2027
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because this is a small, minimal-risk feasibility study containing identifiable clinical data. Aggregate results may be shared in publications and presentations.